nodes	percent_of_prediction	percent_of_DWPC	metapath
Prednisone—ALB—lung cancer	0.16	0.512	CbGaD
Prednisone—ABCB1—lung cancer	0.152	0.488	CbGaD
Prednisone—ALB—Gefitinib—lung cancer	0.0394	0.0921	CbGbCtD
Prednisone—CYP2C19—Gefitinib—lung cancer	0.0255	0.0597	CbGbCtD
Prednisone—CYP2C19—Teniposide—lung cancer	0.0248	0.0579	CbGbCtD
Prednisone—ALB—Erlotinib—lung cancer	0.0233	0.0545	CbGbCtD
Prednisone—ABCB1—Topotecan—lung cancer	0.0225	0.0527	CbGbCtD
Prednisone—SLCO1A2—Methotrexate—lung cancer	0.0215	0.0504	CbGbCtD
Prednisone—ALB—Irinotecan—lung cancer	0.021	0.0492	CbGbCtD
Prednisone—ABCB1—Gefitinib—lung cancer	0.0206	0.0482	CbGbCtD
Prednisone—ABCB1—Vinorelbine—lung cancer	0.0159	0.0371	CbGbCtD
Prednisone—CYP3A4—Topotecan—lung cancer	0.0135	0.0316	CbGbCtD
Prednisone—ABCB1—Crizotinib—lung cancer	0.0126	0.0295	CbGbCtD
Prednisone—CYP3A4—Gefitinib—lung cancer	0.0123	0.0289	CbGbCtD
Prednisone—ABCB1—Gemcitabine—lung cancer	0.0123	0.0289	CbGbCtD
Prednisone—ABCB1—Erlotinib—lung cancer	0.0122	0.0285	CbGbCtD
Prednisone—CYP3A4—Teniposide—lung cancer	0.012	0.028	CbGbCtD
Prednisone—ABCB1—Paclitaxel—lung cancer	0.0112	0.0261	CbGbCtD
Prednisone—ALB—Methotrexate—lung cancer	0.0111	0.026	CbGbCtD
Prednisone—ABCB1—Irinotecan—lung cancer	0.011	0.0257	CbGbCtD
Prednisone—ABCB1—Vinblastine—lung cancer	0.00978	0.0229	CbGbCtD
Prednisone—CYP3A4—Vinorelbine—lung cancer	0.00951	0.0222	CbGbCtD
Prednisone—ABCB1—Cisplatin—lung cancer	0.00897	0.021	CbGbCtD
Prednisone—ABCB1—Etoposide—lung cancer	0.00881	0.0206	CbGbCtD
Prednisone—ABCB1—Docetaxel—lung cancer	0.00806	0.0189	CbGbCtD
Prednisone—CYP3A4—Crizotinib—lung cancer	0.00757	0.0177	CbGbCtD
Prednisone—CYP3A4—Erlotinib—lung cancer	0.0073	0.0171	CbGbCtD
Prednisone—CYP3A4—Paclitaxel—lung cancer	0.00668	0.0156	CbGbCtD
Prednisone—CYP3A4—Irinotecan—lung cancer	0.00659	0.0154	CbGbCtD
Prednisone—ABCB1—Doxorubicin—lung cancer	0.00601	0.0141	CbGbCtD
Prednisone—CYP3A4—Vinblastine—lung cancer	0.00586	0.0137	CbGbCtD
Prednisone—ABCB1—Methotrexate—lung cancer	0.00582	0.0136	CbGbCtD
Prednisone—CYP3A4—Etoposide—lung cancer	0.00528	0.0124	CbGbCtD
Prednisone—CYP3A4—Docetaxel—lung cancer	0.00483	0.0113	CbGbCtD
Prednisone—CYP3A4—Doxorubicin—lung cancer	0.0036	0.00842	CbGbCtD
Prednisone—HSD11B1—respiratory system—lung cancer	0.00251	0.177	CbGeAlD
Prednisone—HSD11B1—bronchus—lung cancer	0.00206	0.146	CbGeAlD
Prednisone—HSD11B1—trachea—lung cancer	0.00185	0.131	CbGeAlD
Prednisone—HSD11B1—lung—lung cancer	0.00133	0.0941	CbGeAlD
Prednisone—ALB—mammary gland—lung cancer	0.00113	0.08	CbGeAlD
Prednisone—Amcinonide—ANXA1—lung cancer	0.00107	0.324	CrCbGaD
Prednisone—HSD11B1—lymph node—lung cancer	0.00091	0.0644	CbGeAlD
Prednisone—NR3C1—respiratory system—lung cancer	0.000474	0.0335	CbGeAlD
Prednisone—Hydrocortisone—ANXA1—lung cancer	0.00045	0.137	CrCbGaD
Prednisone—SLCO1A2—lung—lung cancer	0.000403	0.0285	CbGeAlD
Prednisone—NR3C1—epithelium—lung cancer	0.000397	0.028	CbGeAlD
Prednisone—NR3C1—bronchus—lung cancer	0.000391	0.0276	CbGeAlD
Prednisone—NR3C1—trachea—lung cancer	0.000351	0.0248	CbGeAlD
Prednisone—Dexamethasone—ANXA1—lung cancer	0.000335	0.102	CrCbGaD
Prednisone—NR3C1—cardiac atrium—lung cancer	0.000329	0.0233	CbGeAlD
Prednisone—NR3C1—bone marrow—lung cancer	0.000278	0.0197	CbGeAlD
Prednisone—ALB—lymph node—lung cancer	0.000274	0.0194	CbGeAlD
Prednisone—ABCB1—respiratory system—lung cancer	0.000254	0.018	CbGeAlD
Prednisone—NR3C1—lung—lung cancer	0.000252	0.0178	CbGeAlD
Prednisone—ABCB1—epithelium—lung cancer	0.000212	0.015	CbGeAlD
Prednisone—Clobetasol propionate—CYP1A1—lung cancer	0.000192	0.0584	CrCbGaD
Prednisone—ABCB1—trachea—lung cancer	0.000188	0.0133	CbGeAlD
Prednisone—Prednisolone—CYP2A6—lung cancer	0.00018	0.0548	CrCbGaD
Prednisone—NR3C1—lymph node—lung cancer	0.000172	0.0122	CbGeAlD
Prednisone—ABCB1—bone marrow—lung cancer	0.000149	0.0105	CbGeAlD
Prednisone—ABCB1—lung—lung cancer	0.000135	0.00953	CbGeAlD
Prednisone—Hydrocortisone—ABCG2—lung cancer	0.000123	0.0375	CrCbGaD
Prednisone—Dexamethasone—CYP2A6—lung cancer	0.000103	0.0312	CrCbGaD
Prednisone—Methylprednisolone—ABCB1—lung cancer	9.53e-05	0.0289	CrCbGaD
Prednisone—Triamcinolone—PTGS2—lung cancer	9.45e-05	0.0287	CrCbGaD
Prednisone—ABCB1—lymph node—lung cancer	9.22e-05	0.00652	CbGeAlD
Prednisone—Dexamethasone—ABCG2—lung cancer	9.2e-05	0.0279	CrCbGaD
Prednisone—Betamethasone—PTGS2—lung cancer	7.74e-05	0.0235	CrCbGaD
Prednisone—Feeling abnormal—Irinotecan—lung cancer	7.59e-05	0.000467	CcSEcCtD
Prednisone—Neutropenia—Methotrexate—lung cancer	7.54e-05	0.000464	CcSEcCtD
Prednisone—Gastrointestinal pain—Irinotecan—lung cancer	7.53e-05	0.000463	CcSEcCtD
Prednisone—Oedema—Paclitaxel—lung cancer	7.51e-05	0.000462	CcSEcCtD
Prednisone—Anaphylactic shock—Paclitaxel—lung cancer	7.51e-05	0.000462	CcSEcCtD
Prednisone—Paraesthesia—Cisplatin—lung cancer	7.51e-05	0.000462	CcSEcCtD
Prednisone—Tachycardia—Etoposide—lung cancer	7.48e-05	0.00046	CcSEcCtD
Prednisone—Infection—Paclitaxel—lung cancer	7.46e-05	0.000459	CcSEcCtD
Prednisone—Skin disorder—Etoposide—lung cancer	7.44e-05	0.000458	CcSEcCtD
Prednisone—Erectile dysfunction—Methotrexate—lung cancer	7.43e-05	0.000457	CcSEcCtD
Prednisone—Dry skin—Doxorubicin—lung cancer	7.41e-05	0.000456	CcSEcCtD
Prednisone—Hyperhidrosis—Etoposide—lung cancer	7.4e-05	0.000455	CcSEcCtD
Prednisone—Feeling abnormal—Gemcitabine—lung cancer	7.39e-05	0.000455	CcSEcCtD
Prednisone—Shock—Paclitaxel—lung cancer	7.39e-05	0.000454	CcSEcCtD
Prednisone—Dizziness—Vinorelbine—lung cancer	7.38e-05	0.000454	CcSEcCtD
Prednisone—Nervous system disorder—Paclitaxel—lung cancer	7.36e-05	0.000453	CcSEcCtD
Prednisone—Hypokalaemia—Doxorubicin—lung cancer	7.36e-05	0.000452	CcSEcCtD
Prednisone—Tachycardia—Paclitaxel—lung cancer	7.33e-05	0.000451	CcSEcCtD
Prednisone—Dexamethasone—CYP2E1—lung cancer	7.3e-05	0.0222	CrCbGaD
Prednisone—Anorexia—Etoposide—lung cancer	7.3e-05	0.000449	CcSEcCtD
Prednisone—Skin disorder—Paclitaxel—lung cancer	7.29e-05	0.000449	CcSEcCtD
Prednisone—Body temperature increased—Irinotecan—lung cancer	7.28e-05	0.000448	CcSEcCtD
Prednisone—Abdominal pain—Irinotecan—lung cancer	7.28e-05	0.000448	CcSEcCtD
Prednisone—Decreased appetite—Cisplatin—lung cancer	7.27e-05	0.000447	CcSEcCtD
Prednisone—Hyperhidrosis—Paclitaxel—lung cancer	7.26e-05	0.000446	CcSEcCtD
Prednisone—Anaemia—Docetaxel—lung cancer	7.21e-05	0.000443	CcSEcCtD
Prednisone—Dexamethasone—CYP1A1—lung cancer	7.2e-05	0.0219	CrCbGaD
Prednisone—Depression—Methotrexate—lung cancer	7.17e-05	0.000441	CcSEcCtD
Prednisone—Anorexia—Paclitaxel—lung cancer	7.16e-05	0.00044	CcSEcCtD
Prednisone—Methyltestosterone—ALB—lung cancer	7.15e-05	0.0217	CrCbGaD
Prednisone—Alanine aminotransferase increased—Doxorubicin—lung cancer	7.13e-05	0.000438	CcSEcCtD
Prednisone—Muscular weakness—Doxorubicin—lung cancer	7.13e-05	0.000438	CcSEcCtD
Prednisone—Vomiting—Vinorelbine—lung cancer	7.1e-05	0.000437	CcSEcCtD
Prednisone—Body temperature increased—Gemcitabine—lung cancer	7.09e-05	0.000436	CcSEcCtD
Prednisone—Rash—Vinorelbine—lung cancer	7.04e-05	0.000433	CcSEcCtD
Prednisone—Dermatitis—Vinorelbine—lung cancer	7.03e-05	0.000433	CcSEcCtD
Prednisone—Abdominal distension—Doxorubicin—lung cancer	7.03e-05	0.000432	CcSEcCtD
Prednisone—Headache—Vinorelbine—lung cancer	6.99e-05	0.00043	CcSEcCtD
Prednisone—Syncope—Docetaxel—lung cancer	6.99e-05	0.00043	CcSEcCtD
Prednisone—Feeling abnormal—Cisplatin—lung cancer	6.89e-05	0.000424	CcSEcCtD
Prednisone—Paraesthesia—Etoposide—lung cancer	6.88e-05	0.000423	CcSEcCtD
Prednisone—Loss of consciousness—Docetaxel—lung cancer	6.85e-05	0.000422	CcSEcCtD
Prednisone—Pancreatitis—Doxorubicin—lung cancer	6.85e-05	0.000421	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Paclitaxel—lung cancer	6.84e-05	0.000421	CcSEcCtD
Prednisone—Insomnia—Paclitaxel—lung cancer	6.79e-05	0.000418	CcSEcCtD
Prednisone—Hypersensitivity—Irinotecan—lung cancer	6.78e-05	0.000417	CcSEcCtD
Prednisone—Convulsion—Docetaxel—lung cancer	6.76e-05	0.000416	CcSEcCtD
Prednisone—Paraesthesia—Paclitaxel—lung cancer	6.74e-05	0.000415	CcSEcCtD
Prednisone—Hypertension—Docetaxel—lung cancer	6.73e-05	0.000414	CcSEcCtD
Prednisone—Prednisolone—ABCB1—lung cancer	6.72e-05	0.0204	CrCbGaD
Prednisone—Decreased appetite—Etoposide—lung cancer	6.66e-05	0.000409	CcSEcCtD
Prednisone—Myalgia—Docetaxel—lung cancer	6.64e-05	0.000408	CcSEcCtD
Prednisone—Arthralgia—Docetaxel—lung cancer	6.64e-05	0.000408	CcSEcCtD
Prednisone—Nausea—Vinorelbine—lung cancer	6.63e-05	0.000408	CcSEcCtD
Prednisone—Dyspepsia—Paclitaxel—lung cancer	6.61e-05	0.000407	CcSEcCtD
Prednisone—Body temperature increased—Cisplatin—lung cancer	6.61e-05	0.000406	CcSEcCtD
Prednisone—Asthenia—Irinotecan—lung cancer	6.61e-05	0.000406	CcSEcCtD
Prednisone—Fatigue—Etoposide—lung cancer	6.6e-05	0.000406	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	6.59e-05	0.000406	CcSEcCtD
Prednisone—Betamethasone—ABCB1—lung cancer	6.58e-05	0.02	CrCbGaD
Prednisone—Constipation—Etoposide—lung cancer	6.55e-05	0.000403	CcSEcCtD
Prednisone—Neutropenia—Doxorubicin—lung cancer	6.53e-05	0.000402	CcSEcCtD
Prednisone—Decreased appetite—Paclitaxel—lung cancer	6.53e-05	0.000401	CcSEcCtD
Prednisone—Haemoglobin—Methotrexate—lung cancer	6.49e-05	0.000399	CcSEcCtD
Prednisone—Fatigue—Paclitaxel—lung cancer	6.47e-05	0.000398	CcSEcCtD
Prednisone—Haemorrhage—Methotrexate—lung cancer	6.46e-05	0.000397	CcSEcCtD
Prednisone—Asthenia—Gemcitabine—lung cancer	6.44e-05	0.000396	CcSEcCtD
Prednisone—Constipation—Paclitaxel—lung cancer	6.42e-05	0.000395	CcSEcCtD
Prednisone—Oedema—Docetaxel—lung cancer	6.37e-05	0.000391	CcSEcCtD
Prednisone—Anaphylactic shock—Docetaxel—lung cancer	6.37e-05	0.000391	CcSEcCtD
Prednisone—Weight increased—Doxorubicin—lung cancer	6.36e-05	0.000391	CcSEcCtD
Prednisone—Pruritus—Gemcitabine—lung cancer	6.35e-05	0.00039	CcSEcCtD
Prednisone—Infection—Docetaxel—lung cancer	6.32e-05	0.000389	CcSEcCtD
Prednisone—Weight decreased—Doxorubicin—lung cancer	6.32e-05	0.000389	CcSEcCtD
Prednisone—Feeling abnormal—Etoposide—lung cancer	6.31e-05	0.000388	CcSEcCtD
Prednisone—Hyperglycaemia—Doxorubicin—lung cancer	6.3e-05	0.000388	CcSEcCtD
Prednisone—Diarrhoea—Irinotecan—lung cancer	6.3e-05	0.000387	CcSEcCtD
Prednisone—Gastrointestinal pain—Etoposide—lung cancer	6.26e-05	0.000385	CcSEcCtD
Prednisone—Shock—Docetaxel—lung cancer	6.26e-05	0.000385	CcSEcCtD
Prednisone—Nervous system disorder—Docetaxel—lung cancer	6.24e-05	0.000384	CcSEcCtD
Prednisone—Tachycardia—Docetaxel—lung cancer	6.21e-05	0.000382	CcSEcCtD
Prednisone—Feeling abnormal—Paclitaxel—lung cancer	6.19e-05	0.000381	CcSEcCtD
Prednisone—Skin disorder—Docetaxel—lung cancer	6.18e-05	0.00038	CcSEcCtD
Prednisone—Hypersensitivity—Cisplatin—lung cancer	6.16e-05	0.000379	CcSEcCtD
Prednisone—Gastrointestinal pain—Paclitaxel—lung cancer	6.14e-05	0.000378	CcSEcCtD
Prednisone—Diarrhoea—Gemcitabine—lung cancer	6.14e-05	0.000377	CcSEcCtD
Prednisone—Neuropathy peripheral—Doxorubicin—lung cancer	6.11e-05	0.000375	CcSEcCtD
Prednisone—Dizziness—Irinotecan—lung cancer	6.09e-05	0.000374	CcSEcCtD
Prednisone—Urticaria—Etoposide—lung cancer	6.08e-05	0.000374	CcSEcCtD
Prednisone—Anorexia—Docetaxel—lung cancer	6.07e-05	0.000373	CcSEcCtD
Prednisone—Abdominal pain—Etoposide—lung cancer	6.05e-05	0.000372	CcSEcCtD
Prednisone—Body temperature increased—Etoposide—lung cancer	6.05e-05	0.000372	CcSEcCtD
Prednisone—Eye disorder—Methotrexate—lung cancer	6.03e-05	0.000371	CcSEcCtD
Prednisone—Asthenia—Cisplatin—lung cancer	6e-05	0.000369	CcSEcCtD
Prednisone—Urticaria—Paclitaxel—lung cancer	5.97e-05	0.000367	CcSEcCtD
Prednisone—Abdominal pain—Paclitaxel—lung cancer	5.94e-05	0.000365	CcSEcCtD
Prednisone—Body temperature increased—Paclitaxel—lung cancer	5.94e-05	0.000365	CcSEcCtD
Prednisone—Angiopathy—Methotrexate—lung cancer	5.86e-05	0.00036	CcSEcCtD
Prednisone—Vomiting—Irinotecan—lung cancer	5.85e-05	0.00036	CcSEcCtD
Prednisone—Immune system disorder—Methotrexate—lung cancer	5.83e-05	0.000359	CcSEcCtD
Prednisone—Rash—Irinotecan—lung cancer	5.81e-05	0.000357	CcSEcCtD
Prednisone—Dermatitis—Irinotecan—lung cancer	5.8e-05	0.000357	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Docetaxel—lung cancer	5.8e-05	0.000357	CcSEcCtD
Prednisone—Headache—Irinotecan—lung cancer	5.77e-05	0.000355	CcSEcCtD
Prednisone—Insomnia—Docetaxel—lung cancer	5.76e-05	0.000354	CcSEcCtD
Prednisone—Diarrhoea—Cisplatin—lung cancer	5.72e-05	0.000352	CcSEcCtD
Prednisone—Paraesthesia—Docetaxel—lung cancer	5.72e-05	0.000352	CcSEcCtD
Prednisone—Alopecia—Methotrexate—lung cancer	5.71e-05	0.000351	CcSEcCtD
Prednisone—Vomiting—Gemcitabine—lung cancer	5.7e-05	0.000351	CcSEcCtD
Prednisone—Bradycardia—Doxorubicin—lung cancer	5.69e-05	0.00035	CcSEcCtD
Prednisone—Mental disorder—Methotrexate—lung cancer	5.66e-05	0.000348	CcSEcCtD
Prednisone—Rash—Gemcitabine—lung cancer	5.66e-05	0.000348	CcSEcCtD
Prednisone—Dermatitis—Gemcitabine—lung cancer	5.65e-05	0.000347	CcSEcCtD
Prednisone—Hypersensitivity—Etoposide—lung cancer	5.64e-05	0.000347	CcSEcCtD
Prednisone—Erythema—Methotrexate—lung cancer	5.62e-05	0.000346	CcSEcCtD
Prednisone—Malnutrition—Methotrexate—lung cancer	5.62e-05	0.000346	CcSEcCtD
Prednisone—Haemoglobin—Doxorubicin—lung cancer	5.62e-05	0.000346	CcSEcCtD
Prednisone—Headache—Gemcitabine—lung cancer	5.62e-05	0.000346	CcSEcCtD
Prednisone—Dyspepsia—Docetaxel—lung cancer	5.6e-05	0.000345	CcSEcCtD
Prednisone—Haemorrhage—Doxorubicin—lung cancer	5.59e-05	0.000344	CcSEcCtD
Prednisone—Decreased appetite—Docetaxel—lung cancer	5.53e-05	0.00034	CcSEcCtD
Prednisone—Hypersensitivity—Paclitaxel—lung cancer	5.53e-05	0.00034	CcSEcCtD
Prednisone—Asthenia—Etoposide—lung cancer	5.5e-05	0.000338	CcSEcCtD
Prednisone—Connective tissue disorder—Doxorubicin—lung cancer	5.49e-05	0.000338	CcSEcCtD
Prednisone—Fatigue—Docetaxel—lung cancer	5.49e-05	0.000337	CcSEcCtD
Prednisone—Nausea—Irinotecan—lung cancer	5.47e-05	0.000336	CcSEcCtD
Prednisone—Constipation—Docetaxel—lung cancer	5.44e-05	0.000335	CcSEcCtD
Prednisone—Pruritus—Etoposide—lung cancer	5.42e-05	0.000333	CcSEcCtD
Prednisone—Asthenia—Paclitaxel—lung cancer	5.39e-05	0.000331	CcSEcCtD
Prednisone—Nausea—Gemcitabine—lung cancer	5.33e-05	0.000328	CcSEcCtD
Prednisone—Vomiting—Cisplatin—lung cancer	5.32e-05	0.000327	CcSEcCtD
Prednisone—Pruritus—Paclitaxel—lung cancer	5.31e-05	0.000327	CcSEcCtD
Prednisone—Vision blurred—Methotrexate—lung cancer	5.3e-05	0.000326	CcSEcCtD
Prednisone—Rash—Cisplatin—lung cancer	5.27e-05	0.000324	CcSEcCtD
Prednisone—Dermatitis—Cisplatin—lung cancer	5.27e-05	0.000324	CcSEcCtD
Prednisone—Feeling abnormal—Docetaxel—lung cancer	5.25e-05	0.000323	CcSEcCtD
Prednisone—Diarrhoea—Etoposide—lung cancer	5.24e-05	0.000322	CcSEcCtD
Prednisone—Eye disorder—Doxorubicin—lung cancer	5.23e-05	0.000321	CcSEcCtD
Prednisone—Ill-defined disorder—Methotrexate—lung cancer	5.22e-05	0.000321	CcSEcCtD
Prednisone—Gastrointestinal pain—Docetaxel—lung cancer	5.2e-05	0.00032	CcSEcCtD
Prednisone—Anaemia—Methotrexate—lung cancer	5.2e-05	0.00032	CcSEcCtD
Prednisone—Flushing—Doxorubicin—lung cancer	5.19e-05	0.000319	CcSEcCtD
Prednisone—Hydrocortisone—ABCB1—lung cancer	5.14e-05	0.0156	CrCbGaD
Prednisone—Diarrhoea—Paclitaxel—lung cancer	5.14e-05	0.000316	CcSEcCtD
Prednisone—Angiopathy—Doxorubicin—lung cancer	5.07e-05	0.000312	CcSEcCtD
Prednisone—Malaise—Methotrexate—lung cancer	5.07e-05	0.000312	CcSEcCtD
Prednisone—Dizziness—Etoposide—lung cancer	5.06e-05	0.000311	CcSEcCtD
Prednisone—Immune system disorder—Doxorubicin—lung cancer	5.05e-05	0.000311	CcSEcCtD
Prednisone—Vertigo—Methotrexate—lung cancer	5.05e-05	0.000311	CcSEcCtD
Prednisone—Abdominal pain—Docetaxel—lung cancer	5.03e-05	0.000309	CcSEcCtD
Prednisone—Body temperature increased—Docetaxel—lung cancer	5.03e-05	0.000309	CcSEcCtD
Prednisone—Arrhythmia—Doxorubicin—lung cancer	5e-05	0.000307	CcSEcCtD
Prednisone—Dizziness—Paclitaxel—lung cancer	4.97e-05	0.000305	CcSEcCtD
Prednisone—Nausea—Cisplatin—lung cancer	4.97e-05	0.000305	CcSEcCtD
Prednisone—Alopecia—Doxorubicin—lung cancer	4.94e-05	0.000304	CcSEcCtD
Prednisone—Mental disorder—Doxorubicin—lung cancer	4.9e-05	0.000301	CcSEcCtD
Prednisone—Convulsion—Methotrexate—lung cancer	4.87e-05	0.0003	CcSEcCtD
Prednisone—Vomiting—Etoposide—lung cancer	4.87e-05	0.000299	CcSEcCtD
Prednisone—Erythema—Doxorubicin—lung cancer	4.87e-05	0.000299	CcSEcCtD
Prednisone—Malnutrition—Doxorubicin—lung cancer	4.87e-05	0.000299	CcSEcCtD
Prednisone—Rash—Etoposide—lung cancer	4.83e-05	0.000297	CcSEcCtD
Prednisone—Dermatitis—Etoposide—lung cancer	4.82e-05	0.000297	CcSEcCtD
Prednisone—Headache—Etoposide—lung cancer	4.8e-05	0.000295	CcSEcCtD
Prednisone—Arthralgia—Methotrexate—lung cancer	4.79e-05	0.000294	CcSEcCtD
Prednisone—Myalgia—Methotrexate—lung cancer	4.79e-05	0.000294	CcSEcCtD
Prednisone—Vomiting—Paclitaxel—lung cancer	4.77e-05	0.000294	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	4.75e-05	0.000292	CcSEcCtD
Prednisone—Rash—Paclitaxel—lung cancer	4.73e-05	0.000291	CcSEcCtD
Prednisone—Dermatitis—Paclitaxel—lung cancer	4.73e-05	0.000291	CcSEcCtD
Prednisone—Discomfort—Methotrexate—lung cancer	4.73e-05	0.000291	CcSEcCtD
Prednisone—Headache—Paclitaxel—lung cancer	4.7e-05	0.000289	CcSEcCtD
Prednisone—Hypersensitivity—Docetaxel—lung cancer	4.69e-05	0.000288	CcSEcCtD
Prednisone—Anaphylactic shock—Methotrexate—lung cancer	4.59e-05	0.000282	CcSEcCtD
Prednisone—Vision blurred—Doxorubicin—lung cancer	4.59e-05	0.000282	CcSEcCtD
Prednisone—Asthenia—Docetaxel—lung cancer	4.57e-05	0.000281	CcSEcCtD
Prednisone—Infection—Methotrexate—lung cancer	4.56e-05	0.00028	CcSEcCtD
Prednisone—Nausea—Etoposide—lung cancer	4.55e-05	0.00028	CcSEcCtD
Prednisone—Ill-defined disorder—Doxorubicin—lung cancer	4.52e-05	0.000278	CcSEcCtD
Prednisone—Pruritus—Docetaxel—lung cancer	4.5e-05	0.000277	CcSEcCtD
Prednisone—Dexamethasone—PTGS2—lung cancer	4.5e-05	0.0137	CrCbGaD
Prednisone—Nervous system disorder—Methotrexate—lung cancer	4.5e-05	0.000277	CcSEcCtD
Prednisone—Anaemia—Doxorubicin—lung cancer	4.5e-05	0.000277	CcSEcCtD
Prednisone—Agitation—Doxorubicin—lung cancer	4.47e-05	0.000275	CcSEcCtD
Prednisone—Nausea—Paclitaxel—lung cancer	4.46e-05	0.000274	CcSEcCtD
Prednisone—Skin disorder—Methotrexate—lung cancer	4.46e-05	0.000274	CcSEcCtD
Prednisone—Hyperhidrosis—Methotrexate—lung cancer	4.44e-05	0.000273	CcSEcCtD
Prednisone—Malaise—Doxorubicin—lung cancer	4.39e-05	0.00027	CcSEcCtD
Prednisone—Vertigo—Doxorubicin—lung cancer	4.37e-05	0.000269	CcSEcCtD
Prednisone—Anorexia—Methotrexate—lung cancer	4.37e-05	0.000269	CcSEcCtD
Prednisone—Syncope—Doxorubicin—lung cancer	4.37e-05	0.000268	CcSEcCtD
Prednisone—Diarrhoea—Docetaxel—lung cancer	4.36e-05	0.000268	CcSEcCtD
Prednisone—Loss of consciousness—Doxorubicin—lung cancer	4.28e-05	0.000263	CcSEcCtD
Prednisone—Convulsion—Doxorubicin—lung cancer	4.22e-05	0.000259	CcSEcCtD
Prednisone—Dizziness—Docetaxel—lung cancer	4.21e-05	0.000259	CcSEcCtD
Prednisone—Hypertension—Doxorubicin—lung cancer	4.2e-05	0.000258	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Methotrexate—lung cancer	4.18e-05	0.000257	CcSEcCtD
Prednisone—Insomnia—Methotrexate—lung cancer	4.15e-05	0.000255	CcSEcCtD
Prednisone—Arthralgia—Doxorubicin—lung cancer	4.14e-05	0.000255	CcSEcCtD
Prednisone—Myalgia—Doxorubicin—lung cancer	4.14e-05	0.000255	CcSEcCtD
Prednisone—Anxiety—Doxorubicin—lung cancer	4.13e-05	0.000254	CcSEcCtD
Prednisone—Paraesthesia—Methotrexate—lung cancer	4.12e-05	0.000253	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	4.12e-05	0.000253	CcSEcCtD
Prednisone—Discomfort—Doxorubicin—lung cancer	4.09e-05	0.000252	CcSEcCtD
Prednisone—Vomiting—Docetaxel—lung cancer	4.05e-05	0.000249	CcSEcCtD
Prednisone—Dyspepsia—Methotrexate—lung cancer	4.04e-05	0.000248	CcSEcCtD
Prednisone—Rash—Docetaxel—lung cancer	4.01e-05	0.000247	CcSEcCtD
Prednisone—Dermatitis—Docetaxel—lung cancer	4.01e-05	0.000247	CcSEcCtD
Prednisone—Decreased appetite—Methotrexate—lung cancer	3.99e-05	0.000245	CcSEcCtD
Prednisone—Headache—Docetaxel—lung cancer	3.99e-05	0.000245	CcSEcCtD
Prednisone—Anaphylactic shock—Doxorubicin—lung cancer	3.97e-05	0.000244	CcSEcCtD
Prednisone—Oedema—Doxorubicin—lung cancer	3.97e-05	0.000244	CcSEcCtD
Prednisone—Fatigue—Methotrexate—lung cancer	3.96e-05	0.000243	CcSEcCtD
Prednisone—Infection—Doxorubicin—lung cancer	3.95e-05	0.000243	CcSEcCtD
Prednisone—Shock—Doxorubicin—lung cancer	3.91e-05	0.00024	CcSEcCtD
Prednisone—Nervous system disorder—Doxorubicin—lung cancer	3.9e-05	0.00024	CcSEcCtD
Prednisone—Tachycardia—Doxorubicin—lung cancer	3.88e-05	0.000238	CcSEcCtD
Prednisone—Skin disorder—Doxorubicin—lung cancer	3.86e-05	0.000237	CcSEcCtD
Prednisone—Hyperhidrosis—Doxorubicin—lung cancer	3.84e-05	0.000236	CcSEcCtD
Prednisone—Dexamethasone—ABCB1—lung cancer	3.83e-05	0.0116	CrCbGaD
Prednisone—Anorexia—Doxorubicin—lung cancer	3.79e-05	0.000233	CcSEcCtD
Prednisone—Nausea—Docetaxel—lung cancer	3.78e-05	0.000233	CcSEcCtD
Prednisone—Feeling abnormal—Methotrexate—lung cancer	3.78e-05	0.000233	CcSEcCtD
Prednisone—Gastrointestinal pain—Methotrexate—lung cancer	3.75e-05	0.000231	CcSEcCtD
Prednisone—Urticaria—Methotrexate—lung cancer	3.64e-05	0.000224	CcSEcCtD
Prednisone—Abdominal pain—Methotrexate—lung cancer	3.63e-05	0.000223	CcSEcCtD
Prednisone—Body temperature increased—Methotrexate—lung cancer	3.63e-05	0.000223	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Doxorubicin—lung cancer	3.62e-05	0.000223	CcSEcCtD
Prednisone—Insomnia—Doxorubicin—lung cancer	3.59e-05	0.000221	CcSEcCtD
Prednisone—Paraesthesia—Doxorubicin—lung cancer	3.57e-05	0.000219	CcSEcCtD
Prednisone—Dyspepsia—Doxorubicin—lung cancer	3.5e-05	0.000215	CcSEcCtD
Prednisone—Decreased appetite—Doxorubicin—lung cancer	3.45e-05	0.000212	CcSEcCtD
Prednisone—Fatigue—Doxorubicin—lung cancer	3.42e-05	0.000211	CcSEcCtD
Prednisone—Constipation—Doxorubicin—lung cancer	3.4e-05	0.000209	CcSEcCtD
Prednisone—Hypersensitivity—Methotrexate—lung cancer	3.38e-05	0.000208	CcSEcCtD
Prednisone—Asthenia—Methotrexate—lung cancer	3.29e-05	0.000202	CcSEcCtD
Prednisone—Feeling abnormal—Doxorubicin—lung cancer	3.27e-05	0.000201	CcSEcCtD
Prednisone—Gastrointestinal pain—Doxorubicin—lung cancer	3.25e-05	0.0002	CcSEcCtD
Prednisone—Pruritus—Methotrexate—lung cancer	3.25e-05	0.0002	CcSEcCtD
Prednisone—Urticaria—Doxorubicin—lung cancer	3.16e-05	0.000194	CcSEcCtD
Prednisone—Abdominal pain—Doxorubicin—lung cancer	3.14e-05	0.000193	CcSEcCtD
Prednisone—Body temperature increased—Doxorubicin—lung cancer	3.14e-05	0.000193	CcSEcCtD
Prednisone—Diarrhoea—Methotrexate—lung cancer	3.14e-05	0.000193	CcSEcCtD
Prednisone—Dizziness—Methotrexate—lung cancer	3.03e-05	0.000187	CcSEcCtD
Prednisone—Hypersensitivity—Doxorubicin—lung cancer	2.93e-05	0.00018	CcSEcCtD
Prednisone—Vomiting—Methotrexate—lung cancer	2.92e-05	0.000179	CcSEcCtD
Prednisone—Rash—Methotrexate—lung cancer	2.89e-05	0.000178	CcSEcCtD
Prednisone—Dermatitis—Methotrexate—lung cancer	2.89e-05	0.000178	CcSEcCtD
Prednisone—Headache—Methotrexate—lung cancer	2.87e-05	0.000177	CcSEcCtD
Prednisone—Asthenia—Doxorubicin—lung cancer	2.85e-05	0.000175	CcSEcCtD
Prednisone—Pruritus—Doxorubicin—lung cancer	2.81e-05	0.000173	CcSEcCtD
Prednisone—Nausea—Methotrexate—lung cancer	2.73e-05	0.000168	CcSEcCtD
Prednisone—Diarrhoea—Doxorubicin—lung cancer	2.72e-05	0.000167	CcSEcCtD
Prednisone—Dizziness—Doxorubicin—lung cancer	2.63e-05	0.000162	CcSEcCtD
Prednisone—Vomiting—Doxorubicin—lung cancer	2.53e-05	0.000155	CcSEcCtD
Prednisone—Rash—Doxorubicin—lung cancer	2.5e-05	0.000154	CcSEcCtD
Prednisone—Dermatitis—Doxorubicin—lung cancer	2.5e-05	0.000154	CcSEcCtD
Prednisone—Headache—Doxorubicin—lung cancer	2.49e-05	0.000153	CcSEcCtD
Prednisone—Nausea—Doxorubicin—lung cancer	2.36e-05	0.000145	CcSEcCtD
Prednisone—ALB—Metabolism—GSTA1—lung cancer	1.29e-05	0.000161	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—GSTM1—lung cancer	1.29e-05	0.000161	CbGpPWpGaD
Prednisone—ALB—Metabolism—ABCC3—lung cancer	1.28e-05	0.000159	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—MAPK3—lung cancer	1.27e-05	0.000158	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—B4GALT5—lung cancer	1.27e-05	0.000158	CbGpPWpGaD
Prednisone—ALB—Hemostasis—APOA1—lung cancer	1.27e-05	0.000158	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PLBD1—lung cancer	1.26e-05	0.000157	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—AVP—lung cancer	1.26e-05	0.000156	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	1.25e-05	0.000155	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—ERCC2—lung cancer	1.24e-05	0.000155	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—B4GALT5—lung cancer	1.24e-05	0.000154	CbGpPWpGaD
Prednisone—ALB—Metabolism—AKR1C1—lung cancer	1.24e-05	0.000154	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—GSTA4—lung cancer	1.23e-05	0.000154	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—CYP1A1—lung cancer	1.22e-05	0.000152	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	1.21e-05	0.000151	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—ERCC2—lung cancer	1.21e-05	0.000151	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	1.21e-05	0.00015	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—GSTA4—lung cancer	1.2e-05	0.00015	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—GSTA2—lung cancer	1.2e-05	0.00015	CbGpPWpGaD
Prednisone—ALB—Metabolism—UGT1A1—lung cancer	1.2e-05	0.00015	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	1.19e-05	0.000148	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—GSTA2—lung cancer	1.17e-05	0.000146	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—GSTA1—lung cancer	1.16e-05	0.000144	CbGpPWpGaD
Prednisone—ALB—Metabolism—GNG11—lung cancer	1.16e-05	0.000144	CbGpPWpGaD
Prednisone—ALB—Hemostasis—PIK3CG—lung cancer	1.16e-05	0.000144	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.15e-05	0.000143	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—HSD17B10—lung cancer	1.15e-05	0.000143	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—ABCC3—lung cancer	1.15e-05	0.000143	CbGpPWpGaD
Prednisone—ALB—Hemostasis—EGF—lung cancer	1.14e-05	0.000142	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—GSTA1—lung cancer	1.13e-05	0.000141	CbGpPWpGaD
Prednisone—NR3C1—Generic Transcription Pathway—MYC—lung cancer	1.12e-05	0.00014	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	1.12e-05	0.00014	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—ABCC3—lung cancer	1.12e-05	0.000139	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—AKR1C1—lung cancer	1.11e-05	0.000138	CbGpPWpGaD
Prednisone—ALB—Metabolism—ALDOA—lung cancer	1.1e-05	0.000137	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—APOA1—lung cancer	1.1e-05	0.000136	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—AKR1C1—lung cancer	1.08e-05	0.000135	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—UGT1A1—lung cancer	1.08e-05	0.000134	CbGpPWpGaD
Prednisone—ALB—Hemostasis—CREBBP—lung cancer	1.07e-05	0.000133	CbGpPWpGaD
Prednisone—ALB—Metabolism—NCOA3—lung cancer	1.07e-05	0.000133	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CKB—lung cancer	1.07e-05	0.000133	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—UGT1A1—lung cancer	1.05e-05	0.000131	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.05e-05	0.000131	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—APOA1—lung cancer	1.05e-05	0.000131	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—PIK3CA—lung cancer	1.05e-05	0.00013	CbGpPWpGaD
Prednisone—ALB—Metabolism—ADCY1—lung cancer	1.04e-05	0.00013	CbGpPWpGaD
Prednisone—ALB—Metabolism—ABCG2—lung cancer	1.04e-05	0.00013	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—GNG11—lung cancer	1.04e-05	0.000129	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.03e-05	0.000129	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	1.03e-05	0.000128	CbGpPWpGaD
Prednisone—ALB—Metabolism—HPGDS—lung cancer	1.02e-05	0.000127	CbGpPWpGaD
Prednisone—ALB—Metabolism—ENO2—lung cancer	1.02e-05	0.000127	CbGpPWpGaD
Prednisone—ALB—Hemostasis—PIK3CD—lung cancer	1.02e-05	0.000126	CbGpPWpGaD
Prednisone—ALB—Metabolism—PPP2R1B—lung cancer	1.02e-05	0.000126	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—GNG11—lung cancer	1.02e-05	0.000126	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CNDP2—lung cancer	1.01e-05	0.000125	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GSTM2—lung cancer	1.01e-05	0.000125	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.01e-05	0.000125	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—POMC—lung cancer	1e-05	0.000125	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	9.98e-06	0.000124	CbGpPWpGaD
Prednisone—ALB—Metabolism—GSTT1—lung cancer	9.91e-06	0.000123	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—ALDOA—lung cancer	9.9e-06	0.000123	CbGpPWpGaD
Prednisone—ALB—Metabolism—GCLC—lung cancer	9.79e-06	0.000122	CbGpPWpGaD
Prednisone—ALB—Metabolism—CYP2A6—lung cancer	9.79e-06	0.000122	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—MTMR3—lung cancer	9.79e-06	0.000122	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	9.76e-06	0.000121	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—ALDOA—lung cancer	9.66e-06	0.00012	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—NCOA3—lung cancer	9.61e-06	0.00012	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—APOA1—lung cancer	9.6e-06	0.00012	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PIK3CG—lung cancer	9.59e-06	0.000119	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PGAM1—lung cancer	9.54e-06	0.000119	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	9.45e-06	0.000118	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—NCOA3—lung cancer	9.38e-06	0.000117	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—ADCY1—lung cancer	9.35e-06	0.000116	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—ABCG2—lung cancer	9.35e-06	0.000116	CbGpPWpGaD
Prednisone—ALB—Metabolism—ENO1—lung cancer	9.28e-06	0.000116	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—CREBBP—lung cancer	9.28e-06	0.000115	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	9.25e-06	0.000115	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—ENO2—lung cancer	9.17e-06	0.000114	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—HPGDS—lung cancer	9.17e-06	0.000114	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—POMC—lung cancer	9.13e-06	0.000114	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—ABCG2—lung cancer	9.13e-06	0.000114	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—ADCY1—lung cancer	9.13e-06	0.000114	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—CREBBP—lung cancer	9.11e-06	0.000113	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PPP2R1B—lung cancer	9.11e-06	0.000113	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CYP2A7—lung cancer	9.1e-06	0.000113	CbGpPWpGaD
Prednisone—ALB—Hemostasis—RAF1—lung cancer	9.07e-06	0.000113	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—POMC—lung cancer	8.99e-06	0.000112	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—HPGDS—lung cancer	8.95e-06	0.000111	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—ENO2—lung cancer	8.95e-06	0.000111	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—SDC4—lung cancer	8.91e-06	0.000111	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—GSTT1—lung cancer	8.89e-06	0.000111	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PPP2R1B—lung cancer	8.89e-06	0.000111	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—CREBBP—lung cancer	8.89e-06	0.000111	CbGpPWpGaD
Prednisone—ALB—Hemostasis—PIK3CB—lung cancer	8.86e-06	0.00011	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CYP2A6—lung cancer	8.79e-06	0.000109	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—GCLC—lung cancer	8.79e-06	0.000109	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	8.76e-06	0.000109	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—GSTT1—lung cancer	8.68e-06	0.000108	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CYP2A6—lung cancer	8.58e-06	0.000107	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—GCLC—lung cancer	8.58e-06	0.000107	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—AKT1—lung cancer	8.56e-06	0.000107	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PIK3CD—lung cancer	8.43e-06	0.000105	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	8.42e-06	0.000105	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—ENO1—lung cancer	8.33e-06	0.000104	CbGpPWpGaD
Prednisone—ALB—Metabolism—CYP2E1—lung cancer	8.33e-06	0.000104	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—ALB—lung cancer	8.32e-06	0.000104	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	8.3e-06	0.000103	CbGpPWpGaD
Prednisone—ALB—Metabolism—NQO1—lung cancer	8.23e-06	0.000102	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—lung cancer	8.2e-06	0.000102	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—ENO1—lung cancer	8.13e-06	0.000101	CbGpPWpGaD
Prednisone—ALB—Hemostasis—IL2—lung cancer	8.13e-06	0.000101	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	8.13e-06	0.000101	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GSTA3—lung cancer	8.11e-06	0.000101	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—RRM1—lung cancer	8.11e-06	0.000101	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	8.06e-06	0.0001	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	7.99e-06	9.94e-05	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—RAF1—lung cancer	7.85e-06	9.77e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—B4GALT5—lung cancer	7.63e-06	9.49e-05	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	7.61e-06	9.47e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CYP2E1—lung cancer	7.48e-06	9.3e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—STK11—lung cancer	7.42e-06	9.24e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GSTA4—lung cancer	7.42e-06	9.24e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—NQO1—lung cancer	7.39e-06	9.2e-05	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PIK3CB—lung cancer	7.35e-06	9.15e-05	CbGpPWpGaD
Prednisone—ALB—Hemostasis—EP300—lung cancer	7.3e-06	9.08e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CYP2E1—lung cancer	7.3e-06	9.08e-05	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PTGS2—lung cancer	7.28e-06	9.06e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	7.24e-06	9.01e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GSTA2—lung cancer	7.23e-06	9e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—NQO1—lung cancer	7.21e-06	8.98e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	7.17e-06	8.93e-05	CbGpPWpGaD
Prednisone—ALB—Hemostasis—SRC—lung cancer	7.1e-06	8.83e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GSTA1—lung cancer	6.98e-06	8.68e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PTEN—lung cancer	6.97e-06	8.67e-05	CbGpPWpGaD
Prednisone—ALB—Hemostasis—VEGFA—lung cancer	6.91e-06	8.6e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—ABCC3—lung cancer	6.9e-06	8.59e-05	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	6.88e-06	8.56e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—GSTP1—lung cancer	6.87e-06	8.55e-05	CbGpPWpGaD
Prednisone—ALB—Hemostasis—NRAS—lung cancer	6.83e-06	8.5e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—CAT—lung cancer	6.68e-06	8.32e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—AKR1C1—lung cancer	6.68e-06	8.32e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—STK11—lung cancer	6.66e-06	8.29e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—EP300—lung cancer	6.64e-06	8.27e-05	CbGpPWpGaD
Prednisone—ALB—Hemostasis—MAPK3—lung cancer	6.54e-06	8.14e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—STK11—lung cancer	6.5e-06	8.09e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—ABCB1—lung cancer	6.5e-06	8.09e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—UGT1A1—lung cancer	6.49e-06	8.07e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—TYMS—lung cancer	6.38e-06	7.95e-05	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PTEN—lung cancer	6.35e-06	7.9e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—GSTM1—lung cancer	6.31e-06	7.86e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—lung cancer	6.25e-06	7.79e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GNG11—lung cancer	6.25e-06	7.78e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—GSTP1—lung cancer	6.16e-06	7.67e-05	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—EP300—lung cancer	6.06e-06	7.54e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—GSTP1—lung cancer	6.02e-06	7.49e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CAT—lung cancer	6e-06	7.47e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—CYP1A1—lung cancer	5.98e-06	7.45e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	5.96e-06	7.42e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—ALDOA—lung cancer	5.95e-06	7.41e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—ERCC2—lung cancer	5.93e-06	7.39e-05	CbGpPWpGaD
Prednisone—ALB—Hemostasis—KRAS—lung cancer	5.88e-06	7.31e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CAT—lung cancer	5.86e-06	7.29e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—ABCB1—lung cancer	5.84e-06	7.26e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—NCOA3—lung cancer	5.78e-06	7.2e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—TYMS—lung cancer	5.73e-06	7.13e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—GSTM1—lung cancer	5.67e-06	7.05e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—ADCY1—lung cancer	5.62e-06	7e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—ABCG2—lung cancer	5.62e-06	7e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—TYMS—lung cancer	5.59e-06	6.96e-05	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—MAPK3—lung cancer	5.56e-06	6.92e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—GSTM1—lung cancer	5.53e-06	6.88e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—ENO2—lung cancer	5.51e-06	6.86e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—HPGDS—lung cancer	5.51e-06	6.86e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PPP2R1B—lung cancer	5.48e-06	6.82e-05	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—MYC—lung cancer	5.41e-06	6.73e-05	CbGpPWpGaD
Prednisone—ALB—Hemostasis—PIK3CA—lung cancer	5.4e-06	6.72e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CYP1A1—lung cancer	5.37e-06	6.69e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GSTT1—lung cancer	5.35e-06	6.66e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—ERCC2—lung cancer	5.33e-06	6.63e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CYP2A6—lung cancer	5.29e-06	6.58e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GCLC—lung cancer	5.29e-06	6.58e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CYP1A1—lung cancer	5.24e-06	6.52e-05	CbGpPWpGaD
Prednisone—ALB—Hemostasis—TP53—lung cancer	5.22e-06	6.5e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—ERCC2—lung cancer	5.2e-06	6.47e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—APOA1—lung cancer	5.13e-06	6.39e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—ENO1—lung cancer	5.01e-06	6.24e-05	CbGpPWpGaD
Prednisone—ALB—Hemostasis—HRAS—lung cancer	4.99e-06	6.22e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	4.92e-06	6.12e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—PIK3CG—lung cancer	4.69e-06	5.83e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—APOA1—lung cancer	4.61e-06	5.74e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—APOA1—lung cancer	4.5e-06	5.6e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CYP2E1—lung cancer	4.5e-06	5.6e-05	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PIK3CA—lung cancer	4.48e-06	5.58e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—POMC—lung cancer	4.46e-06	5.55e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—NQO1—lung cancer	4.44e-06	5.53e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	4.41e-06	5.49e-05	CbGpPWpGaD
Prednisone—ALB—Hemostasis—AKT1—lung cancer	4.41e-06	5.49e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—CREBBP—lung cancer	4.34e-06	5.41e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PIK3CG—lung cancer	4.21e-06	5.24e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—PIK3CD—lung cancer	4.12e-06	5.13e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PIK3CG—lung cancer	4.11e-06	5.11e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—STK11—lung cancer	4.01e-06	4.99e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—POMC—lung cancer	4e-06	4.98e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—POMC—lung cancer	3.91e-06	4.86e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CREBBP—lung cancer	3.9e-06	4.85e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CREBBP—lung cancer	3.81e-06	4.74e-05	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—AKT1—lung cancer	3.75e-06	4.67e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GSTP1—lung cancer	3.71e-06	4.61e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PIK3CD—lung cancer	3.7e-06	4.6e-05	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—AKT1—lung cancer	3.66e-06	4.56e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—ALB—lung cancer	3.65e-06	4.54e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PIK3CD—lung cancer	3.61e-06	4.49e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CAT—lung cancer	3.61e-06	4.49e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—PIK3CB—lung cancer	3.59e-06	4.47e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—ALB—lung cancer	3.56e-06	4.44e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—PTGS2—lung cancer	3.56e-06	4.43e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—ABCB1—lung cancer	3.51e-06	4.37e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—TYMS—lung cancer	3.45e-06	4.29e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GSTM1—lung cancer	3.41e-06	4.24e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CYP1A1—lung cancer	3.23e-06	4.02e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PIK3CB—lung cancer	3.22e-06	4.01e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—ERCC2—lung cancer	3.2e-06	3.99e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PTGS2—lung cancer	3.19e-06	3.98e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PIK3CB—lung cancer	3.15e-06	3.92e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PTGS2—lung cancer	3.12e-06	3.88e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—PTEN—lung cancer	3.1e-06	3.86e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—EP300—lung cancer	2.96e-06	3.68e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PTEN—lung cancer	2.79e-06	3.47e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—APOA1—lung cancer	2.77e-06	3.45e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PTEN—lung cancer	2.72e-06	3.38e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—EP300—lung cancer	2.66e-06	3.31e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—EP300—lung cancer	2.59e-06	3.23e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PIK3CG—lung cancer	2.53e-06	3.15e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—POMC—lung cancer	2.41e-06	3e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CREBBP—lung cancer	2.35e-06	2.92e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PIK3CD—lung cancer	2.22e-06	2.77e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—ALB—lung cancer	2.2e-06	2.73e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—PIK3CA—lung cancer	2.19e-06	2.72e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PIK3CA—lung cancer	1.96e-06	2.45e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PIK3CB—lung cancer	1.94e-06	2.41e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PTGS2—lung cancer	1.92e-06	2.39e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PIK3CA—lung cancer	1.92e-06	2.39e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—AKT1—lung cancer	1.79e-06	2.23e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PTEN—lung cancer	1.67e-06	2.08e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—AKT1—lung cancer	1.61e-06	2e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—EP300—lung cancer	1.6e-06	1.99e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—AKT1—lung cancer	1.57e-06	1.95e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PIK3CA—lung cancer	1.18e-06	1.47e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—AKT1—lung cancer	9.65e-07	1.2e-05	CbGpPWpGaD
